本年度信息
微创医疗科学有限公司公告显示，截至2025年12月31日止12个月，收入为1,350,632.69千元，同比增长11.96%。经调整净利润（归属于心脉医疗科技股权持有人）达到563,213.12千元，同比增长12.17%。
公告同时披露，心脉医疗科技截至2025年12月31日的总资产为4,640,467.70千元，同比增长8.13%；归属于股权持有人的总权益为4,075,659.32千元，同比增长7.48%。
本年度信息
微创医疗科学有限公司公告显示，截至2025年12月31日止12个月，收入为1,350,632.69千元，同比增长11.96%。经调整净利润（归属于心脉医疗科技股权持有人）达到563,213.12千元，同比增长12.17%。
公告同时披露，心脉医疗科技截至2025年12月31日的总资产为4,640,467.70千元，同比增长8.13%；归属于股权持有人的总权益为4,075,659.32千元，同比增长7.48%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.